SCORE2-Diabetes Calculator: Advanced Cardiovascular Risk Stratification in Patients with Diabetes
Introduction
Patients with type 2 diabetes are one of the biggest challenges in cardiovascular prevention. Although diabetes itself is a powerful risk factor, patients vary enormously: some are at low to moderate risk, while others have an extremely high probability of a cardiovascular event in the short term.
To provide a more accurate assessment, the model to calculate SCORE2-Diabeteswas developed, a tool designed to calculate 10-year cardiovascular risk in people with diabetes, combining the information from the SCORE2 model with variables specific to the metabolic disease.
CALCULATE SCORE2-DIABETES
- Patient ≥70 years? SCORE2-OP calculator
- Patient without diabetes? SCORE2 calculator
- Patient with established cardiovascular disease? Secondary prevention calculator
Intensity classification (ESC/EAS) — usual doses
- Atorvastatin 10–20 mg
- Rosuvastatin 5–10 mg
- Simvastatin 20–40 mg
- Pravastatin 40–80 mg
- Fluvastatin 80 mg
- Pitavastatin 1–4 mg
- Atorvastatin 40–80 mg
- Rosuvastatin 20–40 mg
Result
- Category
- —
- LDL-C target
- —
- Current LDL-C
- —
- Current treatment
- —
You can also calculate the LDL target in:
- Patients with established cardiovascular disease
- Patients under 70 without diabetes (SCORE2)
- Patients over 70 without diabetes (SCORE2-OP)
What Is SCORE2-Diabetes?
SCORE2-Diabetes is an extended version of the SCORE2 model, developed specifically for patients with type 1 or type 2 diabetes without established cardiovascular disease.
Its purpose is to provide an individualised estimate of the 10-year risk of fatal and non-fatal cardiovascular events, adjusted for the presence of diabetes.
The model takes into account the direct impact of diabetes on atherosclerosis, metabolic control, disease duration and the coexistence of other classic risk factors.
SCORE2-Diabetes therefore allows a finer stratification than the simple "high risk" or "very high risk" label traditionally used.
Variables Included in SCORE2-Diabetes
The model combines the standard SCORE2 variables with diabetes-specific factors.
To calculate SCORE2-Diabetes, the following clinical data must be entered:
- Age: risk increases progressively with age, as in SCORE2.
- Sex: separate equations are applied for men and women.
- Systolic blood pressure (SBP): reflects the degree of haemodynamic control.
- Total cholesterol y HDL cholesterol: determine the lipid profile and its atherogenic ratio.
- Smoking: classified as current smoker or non-smoker.
- Age at diabetes diagnosis: earlier diagnosis means more years of exposure and higher risk.
- Estimated glomerular filtration rate (eGFR): chronic kidney disease increases cardiovascular risk.
- Glycaemic control (HbA1c): high levels indicate greater risk.
- Geographical region: the model is calibrated by risk region; this calculator is already calibrated for Spain (a low-risk region).
When these data are entered, the model produces a total 10-year cardiovascular risk percentage that combines both fatal and non-fatal events (myocardial infarction, stroke, revascularisation or cardiovascular death).
Population to Which SCORE2-Diabetes Applies
SCORE2-Diabetes is designed for adults with type 1 or type 2 diabetes that do not have established cardiovascular disease.
In other words, it applies to primary prevention.
It should not be used in patients with:
- Previous coronary artery disease, stroke or peripheral artery disease.
- Long-standing type 1 diabetes with severe organ damage.
- Advanced kidney failure or severe albuminuria.
In these cases risk is considered very high by definition, and the tool loses predictive value.
Interpreting the SCORE2-Diabetes Result
The model gives a 10-year percentage risk score, interpreted in categories:
- Low/moderate risk: < 5%
- High risk: 5 – 10 %
- Very high risk: ≥ 10 %
However, the interpretation must always be made within the patient's clinical context, considering:
- Duration of diabetes.
- Presence of microalbuminuria or nephropathy.
- Other concomitant factors: hypertension, dyslipidaemia, obesity, smoking.
In practice, many diabetic patients automatically fall into a high or very highrisk range, but SCORE2-Diabetes helps distinguish accurately who really needs more aggressive preventive strategies and who can be managed with less intensive interventions.
Differences Between SCORE2 and SCORE2-Diabetes
| Feature | SCORE2 | SCORE2-Diabetes |
|---|---|---|
| Population | Non-diabetic | Patients with type 1 or type 2 diabetes |
| Additional variables | Does not include diabetes | Adds duration, HbA1c and microangiopathy |
| Type of risk | Fatal and non-fatal | Fatal and non-fatal |
| Goal | General primary prevention | Cardiovascular prevention in people with diabetes |
| Stratification | Low, moderate, high, very high | Adapted to the degree of control and microvascular damage |
SCORE2-Diabetes is therefore the most up-to-date tool for predicting cardiovascular risk in diabetic patients without previous cardiovascular disease.
Clinical Usefulness of Calculating SCORE2-Diabetes
Calculating SCORE2-Diabetes integrates the patient's metabolic and cardiovascular information quantitatively, providing an objective basis for decision-making.
Its main applications include:
- Defining the intensity of lipid-lowering treatment.
In high or very high-risk patients, the LDL target should be below 70 or even 55 mg/dL. - Setting blood pressure targets.
The estimated risk points towards stricter blood pressure goals. - Assessing the benefit of antidiabetic drugs with cardiovascular effects.
Drugs such as SGLT2 inhibitors or GLP-1 agonists show greater benefit the higher the baseline risk. - Optimising clinical follow-up.
High-risk patients should be reviewed more often, with comprehensive treatment of all modifiable factors.
How to Use the SCORE2-Diabetes Calculator in Clinic
The calculator is at the top of the article and is already calibrated for Spain, so there is no need to select a region.
- Check that the patient is type 2 diabetes, aged 40 to 69, and has no established cardiovascular disease or severe target-organ damage.
- Enter the general data: age, and enter sex, smoking status, systolic blood pressure, total cholesterol and HDL cholesterol (in mg/dL or mmol/L).
- Enter the diabetes data: HbA1c (in % or mmol/mol), estimated glomerular filtration rate and age at diabetes diagnosis.
- Check the result: 10-year risk and category (low, moderate, high or very high), to adjust LDL targets and treatment.
Other risk calculators: SCORE2 (40–69 years), SCORE2-OP (≥ 70 years), LDL target.
Special Considerations in Diabetic Patients
- Patients with recent-onset diabetes and good metabolic control may have a relatively low risk.
- Those with microalbuminuria or nephropathy should be considered high risk, even if the final percentage is moderate.
- The estimated risk changes substantially if the patient stops smoking or improves their lipid profile.
- SCORE2-Diabetes can be repeated periodically to monitor how risk changes over time.
Limitations of the Model
- It does not replace clinical judgement or a global assessment of the patient.
- It may underestimate risk in young people with type 1 diabetes.
- It does not include emerging variables such as C-reactive protein or lipoprotein(a).
- It is not designed for secondary prevention.
Even so, it remains the most accurate and practical tool currently available to estimate cardiovascular risk in diabetes.
Integrating SCORE2-Diabetes Into Preventive Practice
Calculating SCORE2-Diabetes should be part of every comprehensive assessment of a diabetic patient.
Its use supports individualised prevention, based on the real risk profile and not just on the diagnosis of diabetes.
- It helps optimise the use of statins, antihypertensives and antidiabetic drugs with proven cardiovascular benefit.
- It encourages more effective communication with the patient, showing how their habits and glycaemic control influence risk.
- It improves coordination between primary care, endocrinology and cardiology.
In short, SCORE2-Diabetes turns cardiovascular prevention into a quantifiable, dynamic process, centred on the patient and supported by current evidence.
Conclusion
Calculate SCORE2-Diabetes gives doctors an accurate, modern tool to estimate the cardiovascular risk of their patients with diabetes.
It distinguishes between different degrees of risk, personalises treatment and defines realistic, effective control targets.
Building it into daily practice contributes to more preventive, rational medicine focused on long-term clinical outcomes.






